Biotech Bets

Investing framework for biotech stocks

Visit Website

Self-Reported Revenue

The creator of Biotech Bets has reported monthly revenues of $0.

This figure was last updated July 27, 2021, and has not been independently verified.

About

Identifying successful biotech stocks is incredibly difficult because of FDA regulations. We want to scratch our own itch and devise a framework for reproducible investment success.